학술논문

Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF
Document Type
Article
Source
In Annals of Oncology July 2014 25(7):1442-1447
Subject
Language
ISSN
0923-7534